OXBDF - Oxford Biomedica plc (OXBDF) CEO John Dawson on Q4 2020 Results - Earnings Call Transcript
Oxford Biomedica plc (OXBDF) Q4 2020 Earnings Conference Call April 15, 2021 08:00 ET Company Participants Catherine Isted - Head, Corporate Development and Investor Relations John Dawson - Chief Executive Officer Stuart Paynter - Chief Financial Officer Kyri Mitrophanous - Chief Scientific Officer Conference Call Participants Amy Walker - Peel Hunt Joe Pantginis - H.C. Wainwright Charles Weston - RBC Brian White - Calvine Partners John Priestner - Edison Investments Alistair Campbell - Liberum Max Herrmann - Stifel Julie Simmonds - Panmure Gordon Presentation Operator Good day, ladies and gentlemen and welcome to the Oxford Biomedica’s Preliminary Results 2020 Briefing. At this time, all participants are in a listen-only mode. [Operator Instructions] I will now hand over to Catherine Isted to open the presentation. Please go ahead. Catherine Isted Good afternoon, ladies and gentlemen. Welcome to Oxford Biomedica’s full year results conference call for the year ending December 31, 2020.
For further details see:
Oxford Biomedica plc (OXBDF) CEO John Dawson on Q4 2020 Results - Earnings Call Transcript